BTIG Initiates Coverage On Quoin Pharmaceuticals with Buy Rating, Announces Price Target of $14

BTIG analyst Jeet Mukherjee has initiated coverage on Quoin Pharmaceuticals (NASDAQ: QNRX) with a Buy rating. The analyst has set a price target of $14 for the company's stock.